newsfilter
← Latest News
GlobeNewswire·

Akari Therapeutics Announces $5.5 Million Private Placement Offering

TAMPA, Fla. and LONDON, May 21, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with a novel RNA splicing modulator payload,